- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02272153
Satiety Effects of the Combination of Egg and Whole Grains
January 14, 2015 updated by: University of Minnesota
The Effects of the Combination of Egg and Whole Grains on Appetite, Blood Glucose Response and Food Intake
The satiety effects of the combination of protein and fiber within egg and whole grain breakfast meals.
High protein with low and high-fiber is hypothesized to be more satiating than low protein, low fiber.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Subjects will consume 3 different breakfast meals.
Satiety will be measured by visual analogue scales; food intake will be recorded at subsequent meal as well as 24 hour food log; blood glucose response will be assessed following test meals.
Subjects will consume an ad libitum lunch meal 3.5 hours after breakfast meal and food intake will be measured.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
St. Paul, Minnesota, United States, 55108
- Department of Food Science and Nutrition
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 64 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy,
- non-smoking,
- BMI of 18-27,
- non-dieting,
- typically consumes breakfast/lunch
Exclusion Criteria:
- distaste for eggs,
- vegetarian,
- current smoker,
- restrained eating habits,
- recent weight change,
- history of significant disease of past medical history,
- pregnant,
- lactating irregular menstrual cycle
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Egg refined grain
Eggs with white toast
|
|
|
Active Comparator: Egg whole grain
Eggs with whole grain toast
|
|
|
Active Comparator: Cereal Refined grain
rice cereal with white toast
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satiety
Time Frame: 210 minutes
|
Measure satiety by visual analog scales (VAS)
|
210 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Food intake
Time Frame: 210 minutes
|
ab libitum lunch provided to assess food intake variation between treatments
|
210 minutes
|
|
Blood glucose response
Time Frame: 180 minutes
|
blood glucose response via finger stick following test meals
|
180 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Joanne L Slavin, PhD, University of Minnesota
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
October 20, 2014
First Submitted That Met QC Criteria
October 21, 2014
First Posted (Estimate)
October 22, 2014
Study Record Updates
Last Update Posted (Estimate)
January 15, 2015
Last Update Submitted That Met QC Criteria
January 14, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 1310M44503
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Selection
-
Kathmandu University School of Medical SciencesResolve to Save LivesRecruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University... and other collaboratorsCompleted
-
The University of Hong KongCompleted
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Laval UniversityMinistère de l'environnement et lutte contre les changements climatiquesCompleted
-
Massachusetts General HospitalGreater Boston Food BankTerminated
-
University of Paris 13Intitut National du CancerCompleted
-
University of MinnesotaCompletedFood SelectionUnited States
-
University of California, DavisCompleted
-
Texas Christian UniversityCompleted
Clinical Trials on Egg refined grain
-
University of CopenhagenTechnical University of DenmarkUnknownMetabolic Disease | Injury of Gastrointestinal TractDenmark
-
University of FloridaGeneral MillsCompleted
-
University of Illinois at Urbana-ChampaignRecruitingCardiovascular Diseases | Dysbiosis | Gastrointestinal Dysfunction | Nutritional and Metabolic DiseasesUnited States
-
Cereal Partners WorldwideCompleted
-
USDA, Western Human Nutrition Research CenterCompletedFood PreferencesUnited States
-
King's College LondonCompleted
-
University of ReadingPepsiCo Global R&DCompleted
-
Florida State UniversityAlliance for Potato Research and EducationCompletedOverweight and Obesity | Type2 Diabetes | Arterial Stiffness | Cardiometabolic SyndromeUnited States
-
Penn State UniversityGeneral MillsCompletedMetabolic Syndrome | Insulin ResistanceUnited States
-
University of Wisconsin, MadisonPepsiCo, Inc.; CIMMYTCompletedβ-cryptoxanthin Bioavailability From Biofortified Maize in HumansUnited States